About Gemini Therapeutics
Gemini Therapeutics is a company based in Cambridge (United States) founded in 2015.. Gemini Therapeutics has raised $44.5 million across 2 funding rounds from investors including Orbimed, Atlas Venture and Lightstone Ventures. The company has 45 employees as of December 31, 2022. Gemini Therapeutics offers products and services including Therapeutic Pipeline and Precision Medicine Platform. Gemini Therapeutics operates in a competitive market with competitors including Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others.
- Headquarter Cambridge, United States
- Employees 45 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Gemini Therapeutics
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$44.5 M (USD)
in 2 rounds
-
Latest Funding Round
$42.5 M (USD), Series A
Oct 17, 2017
-
Investors
Orbimed
& 2 more
-
Employee Count
45
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Gemini Therapeutics
Gemini Therapeutics offers a comprehensive portfolio of products and services, including Therapeutic Pipeline and Precision Medicine Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Develops targeted therapies for genetically-defined eye diseases.
Identifies genetic variants for disease treatment development.
Unlock access to complete
Unlock access to complete
Funding Insights of Gemini Therapeutics
Gemini Therapeutics has successfully raised a total of $44.5M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $42.5 million completed in October 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $42.5M
-
First Round
First Round
(02 May 2016)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2017 | Amount | Series A - Gemini Therapeutics | Valuation | Atlas Venture , Lightstone Ventures |
|
| May, 2016 | Amount | Seed - Gemini Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Gemini Therapeutics
Gemini Therapeutics has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Orbimed, Atlas Venture and Lightstone Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in life science and biotechnology sectors
|
Founded Year | Domain | Location | |
|
Venture capital fund and fund of funds focused on the life science sector
|
Founded Year | Domain | Location | |
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Gemini Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Gemini Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Gemini Therapeutics Comparisons
Competitors of Gemini Therapeutics
Gemini Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases are developed to treat patients.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
Provider of cell therapies to treat cancer and hematologic conditions
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Gemini Therapeutics
Frequently Asked Questions about Gemini Therapeutics
When was Gemini Therapeutics founded?
Gemini Therapeutics was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Where is Gemini Therapeutics located?
Gemini Therapeutics is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Who is the current CEO of Gemini Therapeutics?
Georges Gemayel is the current CEO of Gemini Therapeutics.
Is Gemini Therapeutics a funded company?
Gemini Therapeutics is a funded company, having raised a total of $44.5M across 2 funding rounds to date. The company's 1st funding round was a Seed of $2M, raised on May 02, 2016.
How many employees does Gemini Therapeutics have?
As of Dec 31, 2022, the latest employee count at Gemini Therapeutics is 45.
What does Gemini Therapeutics do?
Gemini Therapeutics was founded in 2015 and is based in Cambridge, United States. The company operates in the biotechnology sector, focusing on precision therapeutics for dry age-related macular degeneration and rare genetic diseases. A genome-driven and multi-modal approach is employed in drug discovery, with treatments targeted to specific genetic mutations and incorporating various modalities rather than a single method.
Who are the top competitors of Gemini Therapeutics?
Gemini Therapeutics's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
What products or services does Gemini Therapeutics offer?
Gemini Therapeutics offers Therapeutic Pipeline and Precision Medicine Platform.
Who are Gemini Therapeutics's investors?
Gemini Therapeutics has 3 investors. Key investors include Orbimed, Atlas Venture, and Lightstone Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.